What is the recommended dose of triamcinolone acetonide (steroid) for a hip bursitis injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Triamcinolone Acetonide Dosage for Hip Bursitis Injection

For hip bursitis injection, the recommended dose of triamcinolone acetonide is 40 mg. 1

Dosage Guidelines

The FDA-approved triamcinolone acetonide dosing for intra-articular injections provides clear guidance:

  • For larger joints (including the hip): 5-15 mg is the initial recommended dose 1
  • However, for adults, doses up to 40 mg for larger areas are typically sufficient 1

The hip trochanteric bursa is considered a larger joint area, and clinical evidence supports using the higher end of the dosing range for optimal therapeutic effect.

Injection Technique

When administering triamcinolone for hip bursitis:

  1. Use strict aseptic technique (mandatory) 2, 1
  2. Shake the vial before use to ensure uniform suspension 1
  3. Inspect for clumping or granular appearance (discard if present) 1
  4. Consider using ultrasound guidance for accurate placement 2
  5. Consider local anesthetic for patient comfort (can be mixed with the injectate) 2

Clinical Evidence Supporting This Dose

Clinical research specifically examining trochanteric bursitis has demonstrated excellent outcomes with corticosteroid injections:

  • In a study of 36 cases of trochanteric bursitis, one or two local corticosteroid injections provided excellent response in two-thirds of patients and improvement in the remaining cases 3
  • Another study found that 15 patients with rheumatoid arthritis and trochanteric bursitis responded well to local corticosteroid injections 4

Important Considerations and Precautions

  • Contraindications: Do not inject at sites of active infection, in patients with hypersensitivity to triamcinolone, or in those with active tuberculosis or systemic fungal infections 5
  • Comorbidities: Use with caution in patients with uncontrolled diabetes, heart failure, or severe hypertension 5
  • Potential adverse effects: Local overdose can result in skin atrophy, pigmentary changes, and telangiectasias 5
  • Timing considerations: Avoid corticosteroid injections for 3 months preceding joint replacement surgery 2
  • Monitoring: Patients with diabetes should be monitored for transient hyperglycemia during days 1-3 post-injection 2

Follow-up Recommendations

  • Most patients experience significant improvement within 48-72 hours after injection
  • Benefits typically last several weeks to months
  • If symptoms recur, a second injection may be considered, but repeated injections should be approached cautiously due to potential long-term negative effects on bone health and joint structure 2
  • If inadequate response after 1-2 injections, consider alternative diagnoses or treatment approaches

By following these evidence-based guidelines for triamcinolone acetonide dosing in hip bursitis, you can optimize pain relief while minimizing potential adverse effects.

References

Guideline

Post-Operative Care for Knee Replacement Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Trochanteric bursitis. Treatment by corticosteroid injection.

Scandinavian journal of rheumatology, 1985

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.